Accel Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LMFP
FWIA
SRIM
DC
CAI
ETC
Accel Wealth Management's MDT Position: Q2 2026 in Review
Accel Wealth Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,459 shares — an estimated $213K sold.
Accel Wealth Management first reported a position in MDT in Q4 2020 and held it in 14 quarters. The position peaked at $235K in Q4 2025. 606 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Accel Wealth Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
- Accel Wealth Management sold 2,459 Medtronic shares in Q2 2026, an estimated $213K.
- Accel Wealth Management first reported a position in Medtronic in Q4 2020 and held it in 14 quarters.
- Accel Wealth Management's Medtronic position peaked at $235K in Q4 2025.
- 606 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Accel Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.